CN Patent
CN116115580A — 一种枸橼酸托法替布缓释片及其制备方法
Assigned to Pku Healthcare Corp ltd · Expires 2023-05-16 · 3y expired
What this patent protects
本发明涉及一种枸橼酸托法替布缓释片及其制备方法,采用单室渗透泵技术,缓释片由片芯、缓释层包衣、速释层包衣组成。本发明将片芯的山梨醇部分替换为吸湿性低的赤藓醇或甘露醇;并通过调节缓释层包衣材料比例和缓释层包衣占片芯的重量,在保证托法替布缓释片的各项指标合格的前提下,避免了生产工艺中的制片粘冲的发生。
USPTO Abstract
本发明涉及一种枸橼酸托法替布缓释片及其制备方法,采用单室渗透泵技术,缓释片由片芯、缓释层包衣、速释层包衣组成。本发明将片芯的山梨醇部分替换为吸湿性低的赤藓醇或甘露醇;并通过调节缓释层包衣材料比例和缓释层包衣占片芯的重量,在保证托法替布缓释片的各项指标合格的前提下,避免了生产工艺中的制片粘冲的发生。
Drugs covered by this patent
- Xeljanz (Tofacitinib Citrate) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.